CO6180507A2 - Derivado de 2-piridincarboxamida que tiene efecto activador de gk - Google Patents
Derivado de 2-piridincarboxamida que tiene efecto activador de gkInfo
- Publication number
- CO6180507A2 CO6180507A2 CO09028706A CO09028706A CO6180507A2 CO 6180507 A2 CO6180507 A2 CO 6180507A2 CO 09028706 A CO09028706 A CO 09028706A CO 09028706 A CO09028706 A CO 09028706A CO 6180507 A2 CO6180507 A2 CO 6180507A2
- Authority
- CO
- Colombia
- Prior art keywords
- nitrogen
- atom
- ring containing
- aliphatic ring
- lower alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1.- Un compuesto representado por la fórmula (I):o una sal farmacéuticamente aceptable del mismo, en la que: cada uno de R1 y R2 representa independientemente un grupo alquilo inferior; X1 representa un grupo de una fórmula (II-1):en la que: cada uno de R11 y R12 representa independientemente un átomo de hidrógeno o un grupo alquilo inferior; R11 y R12 junto con un átomo de nitrógeno al que están unidos, pueden formar un anillo alifático que contiene nitrógeno de 4 a 7 miembros; o un átomo de carbono de (CH2)m y R11 o R12 tomados juntos forman un anillo alifático que contiene nitrógeno de 4 a 7 miembros; un átomo de carbono que constituye el anillo alifático quecontiene nitrógeno de 4 a 7 miembros puede reemplazarse por un átomo de oxígeno; dicho anillo alifático que contiene nitrógeno de 4 a 7 miembros puede estar sustituido con un grupo oxo; un átomo de nitrógeno al que R11 y R12 están unidos puede añadirse con un átomo de oxígeno; cualquier átomo de carbono en (CH2)m puede estar sustituido con un grupo alquilo inferior; y m indica un número entero de 1 a 3, o un grupo de una fórmula (II-2):en la que: cada uno de R21 y R22 representa independientemente un átomo de hidrógeno o un grupo alquilo inferior; o R21, R22 y un átomo de nitrógeno al que están unidos pueden formar un anillo alifático que contiene nitrógeno de 4 a 7 miembros; dicho anillo alifático que contiene nitrógeno de 4 a 7 miembros puede estar sustituido con un grupo oxo; cualquier átomo de carbono en (CH2)n puede estar sustituido con un grupo alquilo inferior; y n indica un número entero de 0 ó 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006275824 | 2006-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6180507A2 true CO6180507A2 (es) | 2010-07-19 |
Family
ID=39282963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09028706A CO6180507A2 (es) | 2006-10-06 | 2009-03-19 | Derivado de 2-piridincarboxamida que tiene efecto activador de gk |
Country Status (22)
Country | Link |
---|---|
US (1) | US8338460B2 (es) |
EP (1) | EP2077266B1 (es) |
JP (1) | JP5292100B2 (es) |
KR (1) | KR20090060426A (es) |
CN (1) | CN101522673A (es) |
AR (1) | AR063028A1 (es) |
AU (1) | AU2007307560B2 (es) |
BR (1) | BRPI0716590A2 (es) |
CA (1) | CA2667068C (es) |
CL (1) | CL2007002890A1 (es) |
CO (1) | CO6180507A2 (es) |
CR (1) | CR10673A (es) |
GT (1) | GT200900065A (es) |
IL (1) | IL197714A0 (es) |
MA (1) | MA30813B1 (es) |
MX (1) | MX2009003073A (es) |
NO (1) | NO20091793L (es) |
PE (1) | PE20081195A1 (es) |
RU (1) | RU2009117209A (es) |
SV (1) | SV2009003196A (es) |
TW (1) | TW200831504A (es) |
WO (1) | WO2008044777A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050101208A (ko) * | 2003-02-13 | 2005-10-20 | 반유 세이야꾸 가부시끼가이샤 | 신규한 2-피리딘 카복사미드 유도체 |
AR063028A1 (es) | 2006-10-06 | 2008-12-23 | Banyu Pharma Co Ltd | Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen. |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2221301B1 (en) | 2007-11-12 | 2014-06-04 | Msd K.K. | Heteroaryloxy quinazoline derivative |
AU2009280579A1 (en) | 2008-08-15 | 2010-02-18 | Banyu Pharmaceutical Co.,Ltd. | Acetyl pyrrolidinyl indole derivative |
JP2012501295A (ja) * | 2008-08-29 | 2012-01-19 | Msd株式会社 | オキソテトラヒドロフラン−2−イル−ベンズイミダゾール誘導体 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
US9527838B2 (en) | 2012-12-17 | 2016-12-27 | Merck Sharp & Dohme Corp. | 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment |
CN113045546A (zh) * | 2021-03-25 | 2021-06-29 | 浙江天宇药业股份有限公司 | 一种吡咯替尼杂质、其制备方法及用途 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
GB2277930A (en) | 1993-05-11 | 1994-11-16 | Shell Int Research | Herbicidal picolinamide derivatives |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
SE0102300D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE519859C2 (sv) | 2001-08-17 | 2003-04-15 | Novacast Ab | Anordning för behandling av järnlegeringar i ett kärl |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
WO2003080585A1 (fr) * | 2002-03-26 | 2003-10-02 | Banyu Pharmaceutical Co., Ltd. | Derive aminobenzamide |
KR20050101208A (ko) | 2003-02-13 | 2005-10-20 | 반유 세이야꾸 가부시끼가이샤 | 신규한 2-피리딘 카복사미드 유도체 |
WO2004076420A1 (ja) * | 2003-02-26 | 2004-09-10 | Banyu Pharmaceutical Co., Ltd. | ヘテロアリールカルバモイルベンゼン誘導体 |
KR101204247B1 (ko) | 2003-07-22 | 2012-11-22 | 아스텍스 테라퓨틱스 리미티드 | 3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도 |
US20050176767A1 (en) | 2003-10-30 | 2005-08-11 | Laval Chan Chun Kong | Pyridine carboxamide and methods for inhibiting HIV integrase |
US7435831B2 (en) | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
GB0412468D0 (en) | 2004-06-04 | 2004-07-07 | Astrazeneca Ab | Chemical compounds |
KR100716891B1 (ko) | 2005-11-01 | 2007-05-09 | (주)아모레퍼시픽 | 피리딘 티아졸 카복사마이드 유도체, 이의 제조방법 및이를 함유하는 피부 미백용 조성물 |
US7951824B2 (en) | 2006-02-17 | 2011-05-31 | Hoffman-La Roche Inc. | 4-aryl-pyridine-2-carboxyamide derivatives |
EP1849785A1 (en) | 2006-04-28 | 2007-10-31 | Neuropharma, S.A. | N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors |
AR063028A1 (es) | 2006-10-06 | 2008-12-23 | Banyu Pharma Co Ltd | Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen. |
-
2007
- 2007-09-27 AR ARP070104280A patent/AR063028A1/es not_active Application Discontinuation
- 2007-10-04 PE PE2007001346A patent/PE20081195A1/es not_active Application Discontinuation
- 2007-10-05 CN CNA2007800374154A patent/CN101522673A/zh active Pending
- 2007-10-05 MX MX2009003073A patent/MX2009003073A/es active IP Right Grant
- 2007-10-05 US US11/973,240 patent/US8338460B2/en active Active
- 2007-10-05 TW TW096137610A patent/TW200831504A/zh unknown
- 2007-10-05 BR BRPI0716590-0A patent/BRPI0716590A2/pt not_active IP Right Cessation
- 2007-10-05 JP JP2008538775A patent/JP5292100B2/ja not_active Expired - Fee Related
- 2007-10-05 WO PCT/JP2007/070014 patent/WO2008044777A1/ja active Application Filing
- 2007-10-05 RU RU2009117209/04A patent/RU2009117209A/ru not_active Application Discontinuation
- 2007-10-05 AU AU2007307560A patent/AU2007307560B2/en not_active Ceased
- 2007-10-05 CA CA2667068A patent/CA2667068C/en not_active Expired - Fee Related
- 2007-10-05 EP EP07829750A patent/EP2077266B1/en active Active
- 2007-10-05 KR KR1020097006965A patent/KR20090060426A/ko not_active Application Discontinuation
- 2007-10-05 CL CL2007002890A patent/CL2007002890A1/es unknown
-
2009
- 2009-03-19 CO CO09028706A patent/CO6180507A2/es not_active Application Discontinuation
- 2009-03-19 CR CR10673A patent/CR10673A/es unknown
- 2009-03-19 IL IL197714A patent/IL197714A0/en unknown
- 2009-03-20 SV SV2009003196A patent/SV2009003196A/es not_active Application Discontinuation
- 2009-03-20 GT GT200900065A patent/GT200900065A/es unknown
- 2009-04-24 MA MA31819A patent/MA30813B1/fr unknown
- 2009-05-05 NO NO20091793A patent/NO20091793L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR063028A1 (es) | 2008-12-23 |
EP2077266A4 (en) | 2010-07-07 |
PE20081195A1 (es) | 2008-09-04 |
EP2077266A1 (en) | 2009-07-08 |
NO20091793L (no) | 2009-05-05 |
US8338460B2 (en) | 2012-12-25 |
CA2667068A1 (en) | 2008-04-17 |
KR20090060426A (ko) | 2009-06-12 |
RU2009117209A (ru) | 2010-11-20 |
JP5292100B2 (ja) | 2013-09-18 |
TW200831504A (en) | 2008-08-01 |
CA2667068C (en) | 2012-03-27 |
AU2007307560B2 (en) | 2012-10-04 |
US20080090799A1 (en) | 2008-04-17 |
MX2009003073A (es) | 2009-04-02 |
CR10673A (es) | 2009-09-03 |
WO2008044777A1 (en) | 2008-04-17 |
JPWO2008044777A1 (ja) | 2010-02-18 |
SV2009003196A (es) | 2009-07-28 |
EP2077266B1 (en) | 2012-07-25 |
CL2007002890A1 (es) | 2008-01-18 |
MA30813B1 (fr) | 2009-10-01 |
CN101522673A (zh) | 2009-09-02 |
BRPI0716590A2 (pt) | 2012-12-25 |
AU2007307560A1 (en) | 2008-04-17 |
GT200900065A (es) | 2010-04-28 |
IL197714A0 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6180507A2 (es) | Derivado de 2-piridincarboxamida que tiene efecto activador de gk | |
ECSP10010060A (es) | Derivados de pirazol sustituídos | |
CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
CU23926B1 (es) | Derivado de oxopirazina y herbicida | |
CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
ECSP099638A (es) | Nuevo compuesto de adenina | |
RS51943B (en) | PIPERIDINSKI GPCR AGONIST | |
ECSP099324A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
MX346367B (es) | Derivado de triazina y composicion farmaceutica que tiene actividad analgesica que comprende el mismo. | |
AR056519A1 (es) | 4-feniltetrahidroisoquinolinas sustituidas, composiciones farmaceuticas que las contienen y usos terapeuticos en trastornos renales, respiratorios y otros | |
DOP2010000046A (es) | Compuestos de biciclolactama sustituida | |
CO5690607A2 (es) | Compuestos de piridina como inhibidores de dipeptidil peptidasa iv | |
MX340060B (es) | Nuevos derivados de 6-triazolopiridazina-sulfanil benzotiazol y bencimidazol, su proceso de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nuevo uso principalmente como inhibidores de met. | |
NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
AR064258A1 (es) | Inhibidores macrociclicos del virus de hepatitis c | |
MX2011008362A (es) | Derivado novedoso de triazina y composicion farmaceutica que comprende el mismo. | |
UY31712A1 (es) | Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen | |
CO6341610A2 (es) | Compuesto heterociclilo aromatico que contiene nitrogeno. | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
NO20076680L (no) | Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter | |
SV2009003348A (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen | |
PA8776401A1 (es) | Nuevos compuestos hetericiclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2478518T3 (es) | Compuesto derivado de ciclohexano | |
TW200738681A (en) | Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |